You are here: Industry Insights > TRACON

News List

TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock firstwordpharma
July 22, 2021
TRACON today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 2,617,802 shares of the Company's common stock
I-Mab, TRACON initiate Phase 1 Trial of the CD73 antibody TJD5 biospectrumasia
August 04, 2019
TJD5, a novel, differentiated humanized antibody against CD73
TRACON terminates Phase III trial for TRC105, Votrient combination in angiosarcoma; shares plunge firstwordpharma
April 14, 2019
Shares in TRACON Pharmaceuticals dropped as much as 45 percent Friday after the company said it was ending ……
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs pharmafocusasia
December 03, 2018
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer......